MarketInOut Stock Screener Log In | Sign Up

Lonza Group AG

OTC • Healthcare • Diagnostics & Research • Quote as of 10/30/2026
Lonza Group AG stock price and volume chart

Company Profile

IndustryDiagnostics & Research
SectorHealthcare
ExchangeOTC
Market Capitalization53,204 mln
Float69.40 mln
Earnings Date01/28/2027

EPS

19.01
Stretched

P / E

40.58
High premium

Piotroski F-Score

6 / 9
Solid

Beneish M-Score

-3.12
Reliable

Relative Strength

84 / 100
Strongly outperforming

Debt / Equity

0.51
Moderate leverage

Business Description

Lonza Group AG is a Swiss company founded in 1897 and based in Basel, that helps pharmaceutical and biotechnology firms develop and manufacture a wide range of medical treatments. The company serves clients across Europe, the Americas, Asia, and beyond, producing everything from biological drugs and small chemical compounds to advanced therapies involving cells, genes, and mRNA. With over a century of experience, Lonza covers the full journey from early development through to large-scale commercial production.

Key Fundamentals

EPS19.01
P/E40.58
ROE-1.38
RPS109
ROIC8.55
ROA-0.61
Interest Cover13.18
EBITDA, mln2,520
EV / EBITDA24.09
EV / EBIT34.38
Revenue, mln7,983
EV / Revenue7.60

Quote Details

Last 771.3530
Change -3.15 (-0.41%)
Open 781.0000
Volume 533
Turnover 411,131
Average Volume 252.24

Financial Ratios

Pre-Tax Profit Margin20
Leverage Ratio2.25
Current Ratio1.66
Price / Book5.47
Price / Tangible Book7.60
Price / Cash Flow30.48
Price / Free Cash Flow207
Debt / Equity0.51
Price / Sales7.03
PEG Ratio1.10

Financial Strength

Altman Z-Score4.11
Piotroski F-Score 6 / 9
Beneish M-Score-3.12
Price to Intrinsic Value9.07
Shiller PE Ratio52.91

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 0.37% 61 / 100   
1 Month 13.07% 90 / 100   
2 Months 9.46% 78 / 100   
6 Months 22.39% 83 / 100   
1 Year 7.1% 58 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog